Current
$133B
5-Year Average
$124B
All-Time High
$174B
All-Time Low
$34.6B
Market cap daily chart for Bristol-Myers Squibb (BMY)
Aug 2, 2021 – Jul 31, 2026 · 1,255 trading days
Market Cap growth chart for Bristol-Myers Squibb (BMY) from 2017 to 2026
Latest: +21.2%
Market Cap history table for Bristol-Myers Squibb (BMY) from 1987 to 2026
| 2026 | $133B | +21.2% | +$23.4B | ||
| 2025 | $110B | -4.0% | -$4.56B | ||
| 2024 | $115B | +7.5% | +$8.02B | ||
| 2023 | $107B | -30.9% | -$47.8B | ||
| 2022 | $154B | +10.3% | +$14.4B | ||
| 2021 | $140B | -0.1% | -$88M | ||
| 2020 | $140B | +27.5% | +$30.2B | ||
| 2019 | $110B | +29.1% | +$24.8B | ||
| 2018 | $85.1B | -15.9% | -$16.1B | ||
| 2017 | $101B | +3.1% | +$3.06B | ||
| 2016 | $98.2B | -15.0% | -$17.3B | ||
| 2015 | $115B | +17.2% | +$16.9B | ||
| 2014 | $98.6B | +11.6% | +$10.2B | ||
| 2013 | $88.3B | +60.6% | +$33.3B | ||
| 2012 | $55B | -9.1% | -$5.5B | ||
| 2011 | $60.5B | +32.3% | +$14.8B | ||
| 2010 | $45.7B | -8.4% | -$4.21B | ||
| 2009 | $49.9B | +7.4% | +$3.42B | ||
| 2008 | $46.5B | -11.4% | -$5.99B | ||
| 2007 | $52.5B | +1.6% | +$843M | ||
| 2006 | $51.7B | +13.4% | +$6.1B | ||
| 2005 | $45.6B | -10.0% | -$5.06B | ||
| 2004 | $50.6B | -9.2% | -$5.14B | ||
| 2003 | $55.8B | +19.5% | +$9.1B | ||
| 2002 | $46.7B | -53.4% | -$53.5B | ||
| 2001 | $100B | -28.7% | -$40.4B | ||
| 2000 | $141B | +13.5% | +$16.7B | ||
| 1999 | $124B | -4.3% | -$5.5B | ||
| 1998 | $129B | +40.7% | +$37.4B | ||
| 1997 | $92B | +74.1% | +$39.2B | ||
| 1996 | $52.8B | +27.2% | +$11.3B | ||
| 1995 | $41.5B | +48.0% | +$13.5B | ||
| 1994 | $28.1B | -1.9% | -$545M | ||
| 1993 | $28.6B | -12.9% | -$4.24B | ||
| 1992 | $32.8B | -24.7% | -$10.8B | ||
| 1991 | $43.6B | +31.5% | +$10.4B | ||
| 1990 | $33.2B | +20.0% | +$5.53B | ||
| 1989 | $27.7B | +22.9% | +$5.15B | ||
| 1988 | $22.5B | +6.3% | +$1.34B | ||
| 1987 | $21.2B | — | — |
- 2026$133B+21.2%
- 2025$110B-4.0%
- 2024$115B+7.5%
- 2023$107B-30.9%
- 2022$154B+10.3%
- 2021$140B-0.1%
- 2020$140B+27.5%
- 2019$110B+29.1%
- 2018$85.1B-15.9%
- 2017$101B+3.1%
- 2016$98.2B-15.0%
- 2015$115B+17.2%
- 2014$98.6B+11.6%
- 2013$88.3B+60.6%
- 2012$55B-9.1%
- 2011$60.5B+32.3%
- 2010$45.7B-8.4%
- 2009$49.9B+7.4%
- 2008$46.5B-11.4%
- 2007$52.5B+1.6%
- 2006$51.7B+13.4%
- 2005$45.6B-10.0%
- 2004$50.6B-9.2%
- 2003$55.8B+19.5%
- 2002$46.7B-53.4%
- 2001$100B-28.7%
- 2000$141B+13.5%
- 1999$124B-4.3%
- 1998$129B+40.7%
- 1997$92B+74.1%
- 1996$52.8B+27.2%
- 1995$41.5B+48.0%
- 1994$28.1B-1.9%
- 1993$28.6B-12.9%
- 1992$32.8B-24.7%
- 1991$43.6B+31.5%
- 1990$33.2B+20.0%
- 1989$27.7B+22.9%
- 1988$22.5B+6.3%
- 1987$21.2B—
Market Cap values are taken from Bristol-Myers Squibb's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's latest reported market cap is $124B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2026, Bristol-Myers Squibb (BMY) market cap totalled $133B – grew 21.2% year-over-year.
Bristol-Myers Squibb market cap compound annual growth for the 2021–2026 (5 years) window is -0.9%, with a net decline across the window.
Between 2022 and 2026, Bristol-Myers Squibb market cap declined 13.6%, falling from $154B to $133B.
Across the available history, market cap reached its high of $154B in 2022 and its low of $21.2B in 1987.
Bristol-Myers Squibb Market Cap by Year
Bristol-Myers Squibb Market Cap 2026: $133B
In 2026, Bristol-Myers Squibb reported market cap of $133B, grew 21.2% from 2025.
Bristol-Myers Squibb Market Cap 2025: $110B
Bristol-Myers Squibb market cap in 2025 was $110B, edged down 4.0% below 2024.
Bristol-Myers Squibb Market Cap 2024: $115B
2024's market cap for Bristol-Myers Squibb came in at $115B, grew 7.5% from 2023.
Bristol-Myers Squibb Market Cap 2023: $107B
Bristol-Myers Squibb posted market cap of $107B in 2023, plunged 30.9% below 2022.
Bristol-Myers Squibb Market Cap 2022: $154B
Bristol-Myers Squibb market cap in 2022 was $154B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers by Market Cap
Healthcare peers of Bristol-Myers Squibb (BMY), ranked by their latest market cap
| $1.08T | |
| $618B | |
| $443B | |
| $376B | |
| $322B | |
| $213B | |
| $209B | |
| $208B |
- $1.08T
- $443B
- $322B
- $209B
- $208B
Frequently asked questions
Test yourself on BMY
Market Cap — 10 rounds, every one of them BMY against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Bristol-Myers Squibb (BMY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.08% TTM
- Dividend Profile3.84% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History6 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.